{"title":"AI-assisted assessment of fall risk in multiple sclerosis: A systematic literature review","authors":"Somayeh Mehrlatifan, Razieh Yousefian Molla","doi":"10.1016/j.msard.2024.105918","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Multiple sclerosis (MS) is an autoimmune disease that can increase the risk of falls in patients due to various factors. Traditional clinical assessments may not effectively identify those at risk of falling.</div></div><div><h3>Objective</h3><div>This study aimed to use artificial intelligence and machine learning techniques to predict the likelihood of falls in patients with MS based on a review of previous research.</div></div><div><h3>Methods</h3><div>A systematic review was conducted following PRISMA guidelines, searching electronic databases from 1990 to 2024. Data extraction and quality assessment were carried out.</div></div><div><h3>Results</h3><div>Seven studies were analyzed, and it was determined that patient-reported outcomes (PROs) such as MSWS-12 and EMIQ performed better than other methods. Sensor-based systems such as GAITRite and Mobility Lab achieved high F1 scores. Random forest classifiers utilizing postural sway measures were effective in discriminating low-risk MS patients from healthy controls. Deep learning models, particularly BiLSTM architectures, outperformed traditional machine learning approaches in identifying recent fallers using wearable accelerometer data.</div></div><div><h3>Conclusion</h3><div>The findings highlight the potential of PROs, the promise of wearable sensors and deep learning, and the importance of optimizing data collection for effective fall risk assessment in the MS population.</div></div>","PeriodicalId":18958,"journal":{"name":"Multiple sclerosis and related disorders","volume":"92 ","pages":"Article 105918"},"PeriodicalIF":2.9000,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple sclerosis and related disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211034824004942","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Multiple sclerosis (MS) is an autoimmune disease that can increase the risk of falls in patients due to various factors. Traditional clinical assessments may not effectively identify those at risk of falling.
Objective
This study aimed to use artificial intelligence and machine learning techniques to predict the likelihood of falls in patients with MS based on a review of previous research.
Methods
A systematic review was conducted following PRISMA guidelines, searching electronic databases from 1990 to 2024. Data extraction and quality assessment were carried out.
Results
Seven studies were analyzed, and it was determined that patient-reported outcomes (PROs) such as MSWS-12 and EMIQ performed better than other methods. Sensor-based systems such as GAITRite and Mobility Lab achieved high F1 scores. Random forest classifiers utilizing postural sway measures were effective in discriminating low-risk MS patients from healthy controls. Deep learning models, particularly BiLSTM architectures, outperformed traditional machine learning approaches in identifying recent fallers using wearable accelerometer data.
Conclusion
The findings highlight the potential of PROs, the promise of wearable sensors and deep learning, and the importance of optimizing data collection for effective fall risk assessment in the MS population.
期刊介绍:
Multiple Sclerosis is an area of ever expanding research and escalating publications. Multiple Sclerosis and Related Disorders is a wide ranging international journal supported by key researchers from all neuroscience domains that focus on MS and associated disease of the central nervous system. The primary aim of this new journal is the rapid publication of high quality original research in the field. Important secondary aims will be timely updates and editorials on important scientific and clinical care advances, controversies in the field, and invited opinion articles from current thought leaders on topical issues. One section of the journal will focus on teaching, written to enhance the practice of community and academic neurologists involved in the care of MS patients. Summaries of key articles written for a lay audience will be provided as an on-line resource.
A team of four chief editors is supported by leading section editors who will commission and appraise original and review articles concerning: clinical neurology, neuroimaging, neuropathology, neuroepidemiology, therapeutics, genetics / transcriptomics, experimental models, neuroimmunology, biomarkers, neuropsychology, neurorehabilitation, measurement scales, teaching, neuroethics and lay communication.